181 related articles for article (PubMed ID: 10846517)
1. Menopausal hormones and breast cancer in a biracial population.
Moorman PG; Kuwabara H; Millikan RC; Newman B
Am J Public Health; 2000 Jun; 90(6):966-71. PubMed ID: 10846517
[TBL] [Abstract][Full Text] [Related]
2. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
[TBL] [Abstract][Full Text] [Related]
3. Associations of Premenopausal Hysterectomy and Oophorectomy With Breast Cancer Among Black and White Women: The Carolina Breast Cancer Study, 1993-2001.
Robinson WR; Nichols HB; Tse CK; Olshan AF; Troester MA
Am J Epidemiol; 2016 Sep; 184(5):388-99. PubMed ID: 27555487
[TBL] [Abstract][Full Text] [Related]
4. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study.
Troisi RJ; Speizer FE; Willett WC; Trichopoulos D; Rosner B
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1183-8. PubMed ID: 7551368
[TBL] [Abstract][Full Text] [Related]
5. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
[TBL] [Abstract][Full Text] [Related]
6. Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women.
Chlebowski RT; Aragaki AK; Anderson GL; Prentice RL
Cancer; 2020 Jul; 126(13):2956-2964. PubMed ID: 32212335
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormones and risk of ovarian cancer.
Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
[TBL] [Abstract][Full Text] [Related]
8. Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study.
Hall IJ; Newman B; Millikan RC; Moorman PG
Am J Epidemiol; 2000 Apr; 151(8):754-64. PubMed ID: 10965972
[TBL] [Abstract][Full Text] [Related]
9. Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54.
Mayberry RM
Ann Epidemiol; 1994 May; 4(3):205-13. PubMed ID: 8055121
[TBL] [Abstract][Full Text] [Related]
10. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.
Li CI; Daling JR; Haugen KL; Tang MT; Porter PL; Malone KE
Breast Cancer Res Treat; 2014 Jun; 145(2):481-9. PubMed ID: 24748570
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives, menopausal estrogens, and the risk of breast cancer: a case-control study in Greece.
Lipworth L; Katsouyanni K; Stuver S; Samoli E; Hankinson SE; Trichopoulos D
Int J Cancer; 1995 Sep; 62(5):548-51. PubMed ID: 7665225
[TBL] [Abstract][Full Text] [Related]
12. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones.
La Vecchia C; Ron E; Franceschi S; Dal Maso L; Mark SD; Chatenoud L; Braga C; Preston-Martin S; McTiernan A; Kolonel L; Mabuchi K; Jin F; Wingren G; Galanti MR; Hallquist A; Lund E; Levi F; Linos D; Negri E
Cancer Causes Control; 1999 Apr; 10(2):157-66. PubMed ID: 10231164
[TBL] [Abstract][Full Text] [Related]
13. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
Shapiro S
Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
[No Abstract] [Full Text] [Related]
14. Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy.
Brinton LA; Brogan DR; Coates RJ; Swanson CA; Potischman N; Stanford JL
Menopause; 2018 Nov; 25(11):1195-1200. PubMed ID: 30358713
[TBL] [Abstract][Full Text] [Related]
15. Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women.
Brinton LA; Gammon MD; Malone KE; Schoenberg JB; Daling JR; Coates RJ
Contraception; 1997 Apr; 55(4):197-203. PubMed ID: 9179450
[TBL] [Abstract][Full Text] [Related]
16. Hormonal therapy and risk of breast cancer in mexican women.
Amadou A; Fabre A; Torres-Mejía G; Ortega-Olvera C; Angeles-Llerenas A; McKenzie F; Biessy C; Hainaut P; Romieu I
PLoS One; 2013; 8(11):e79695. PubMed ID: 24260282
[TBL] [Abstract][Full Text] [Related]
17. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
18. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives and the risk of breast cancer.
Marchbanks PA; McDonald JA; Wilson HG; Folger SG; Mandel MG; Daling JR; Bernstein L; Malone KE; Ursin G; Strom BL; Norman SA; Wingo PA; Burkman RT; Berlin JA; Simon MS; Spirtas R; Weiss LK
N Engl J Med; 2002 Jun; 346(26):2025-32. PubMed ID: 12087137
[TBL] [Abstract][Full Text] [Related]
20. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
